Brevan Howard Capital Management LP

Position in SENS — Senseonics Holdings, Inc.

CIK 1512857 ST. HELIER, Y9

Back to SENS Full portfolio

Position in SENS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$164,214

+$76,988 QoQ

Shares Held

28,911

+120.7% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#42

of 111 holders

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in SENS Over Time

Shares Held

Position Value (USD)

Derivatives in SENS

reported options exposure · as of Mar 31, 2026

CallValue

$112,554

CallShares

16,900

PutValue

$228,198

PutShares

34,264

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Brevan Howard Capital Management LP holds $43,939,264 across 35 Medical Devices names. SENS ranks #31 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	STE	STERIS plc	20,654	$4,349,112
2	BIO	Bio-Rad Laboratories, Inc.	13,718	$4,027,741
3	UFPT	Ufp Technologies Inc	13,400	$3,552,742
4	EW	Edwards Lifesciences Corp	34,889	$3,156,058
5	BSX	Boston Scientific Corp	68,883	$2,939,925
6	SYK	Stryker Corp	9,013	$2,837,652
7	IRTC	iRhythm Holdings, Inc.	23,847	$2,836,600
8	DXCM	Dexcom Inc	32,813	$2,209,955

All Filings in SENS

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$164,214	28,911	+120.7%	Shares	Defined	2026-08-14
2026-03-31	$87,226	13,097	-20.9%	Shares	Defined	2026-05-15
2026-03-31	$112,554	16,900	—	Call	Defined	2026-05-15
2026-03-31	$228,198	34,264	—	Put	Defined	2026-05-15
2025-09-30	$7,219	16,559	—	Shares	Defined	2025-11-14
No filing history on record for this holder in this stock.